Also at the authors’ institution, which has an extremely low rate of patients with EGFR mutations or other targetable alterations influencing first-line treatment (Nieder et al. 2020), early radiotherapy was the prevailing strategy for patients with brain metastases from lung cancer undergoing active treatment rather than supportive, palliative measures. This evidence concerns the gene EGFR and lung cancer.